Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 4, Randomized Trial to Assess the Safety and Immunogenicity of Inactivated Poliovirus Vaccine When Given Concomitantly With Measles and Rubella Combined Vaccine and Yellow Fever Vaccine at Nine Months and When Administered Via Different Vaccination Routes
Brief Summary: The overall goal of this study is to identify interference between intramuscular Inactivated Polio Vaccine (IPV) and other vaccines (Measles Rubella and Yellow Fever) co-administered at nine months of age and to confirm the safety of co-administration. In addition, the study will compare the immunogenicity and safety of IPV when administered via different routes.

A total of 1504 healthy infants between the ages of nine to ten months, who have completed their primary immunizations, including at least three doses of trivalent Oral Polio Vaccine (tOPV) will be recruited for this study.


Options:
A: Arm Label: IPV IM (Visit 1); Type: EXPERIMENTAL; Interventions: Drug: IPV IM Needle | Arm Label: IPV IM (Visit 2); Type: EXPERIMENTAL; Interventions: Drug: IPV IM Needle | Arm Label: IPV IM (Device - Visit 2); Type: EXPERIMENTAL; Interventions: Drug: IPV IM Device | Arm Label: IPV IM and MR (Visit1); Type: EXPERIMENTAL; Interventions: Drug: IPV IM Needle | Arm Label: IPV IM and YF (Visit 1); Type: EXPERIMENTAL; Interventions: Drug: IPV IM Needle | Arm Label: IPV ID (Visit 2); Type: EXPERIMENTAL; Interventions: Drug: IPV ID Needle | Arm Label: IPV IM and MR and YF (Visit 1); Type: EXPERIMENTAL; Interventions: Drug: IPV IM Needle | Arm Label: IPV (ID Device Visit 2); Type: EXPERIMENTAL; Interventions: Drug: IPV ID Device | Intervention Type: DRUG; Name: IPV IM Needle; Assigned to Arm(s): IPV IM (Visit 1), IPV IM (Visit 2), IPV IM and MR (Visit1), IPV IM and MR and YF (Visit 1), IPV IM and YF (Visit 1) | Intervention Type: DRUG; Name: IPV ID Needle; Assigned to Arm(s): IPV ID (Visit 2) | Intervention Type: DRUG; Name: IPV IM Device; Assigned to Arm(s): IPV IM (Device - Visit 2) | Intervention Type: DRUG; Name: IPV ID Device; Assigned to Arm(s): IPV (ID Device Visit 2)
B: Arm Label: Kinrix + M-M-R II + Varivax; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals'Kinrix®, Biological: Merck and Company's MMRII, Biological: Merck and Company's Varivax | Arm Label: Kinrix + M-M-R II -> Varivax; Type: ACTIVE_COMPARATOR; Interventions: Biological: GSK Biologicals'Kinrix®, Biological: Merck and Company's MMRII, Biological: Merck and Company's Varivax | Intervention Type: BIOLOGICAL; Name: GSK Biologicals'Kinrix®; Assigned to Arm(s): Kinrix + M-M-R II + Varivax, Kinrix + M-M-R II -> Varivax | Intervention Type: BIOLOGICAL; Name: Merck and Company's MMRII; Assigned to Arm(s): Kinrix + M-M-R II + Varivax, Kinrix + M-M-R II -> Varivax | Intervention Type: BIOLOGICAL; Name: Merck and Company's Varivax; Assigned to Arm(s): Kinrix + M-M-R II + Varivax, Kinrix + M-M-R II -> Varivax
C: Intervention Type: BIOLOGICAL; Name: Inactivated Polio Vaccine given at an accelerated schedule; Assigned to Arm(s): N/A
D: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Biological: Inactivated Poliomyelitis vaccine (IMOVAX) | Arm Label: Group B; Type: ACTIVE_COMPARATOR; Interventions: Biological: Inactivated Poliomyelitis vaccine (IMOVAX) | Intervention Type: BIOLOGICAL; Name: Inactivated Poliomyelitis vaccine (IMOVAX); Assigned to Arm(s): Group A | Intervention Type: BIOLOGICAL; Name: Inactivated Poliomyelitis vaccine (IMOVAX); Assigned to Arm(s): Group B

Answer: A